Intermittent hypoxia changes the interaction of the kinin-VEGF system and impairs myocardial angiogenesis in the hypertrophic heart.


Journal

Physiological reports
ISSN: 2051-817X
Titre abrégé: Physiol Rep
Pays: United States
ID NLM: 101607800

Informations de publication

Date de publication:
05 2021
Historique:
revised: 29 03 2021
received: 08 01 2021
accepted: 13 04 2021
entrez: 15 5 2021
pubmed: 16 5 2021
medline: 11 1 2022
Statut: ppublish

Résumé

Intermittent hypoxia (IH) is a feature of obstructive sleep apnea (OSA), a condition highly associated with hypertension-related cardiovascular diseases. Repeated episodes of IH contribute to imbalance of angiogenic growth factors in the hypertrophic heart, which is key in the progression of cardiovascular complications. In particular, the interaction between vascular endothelial growth factor (VEGF) and the kallikrein-kinin system (KKS) is essential for promoting angiogenesis. However, researchers have yet to investigate experimental models of IH that reproduce OSA, myocardial angiogenesis, and expression of KKS components. We examined temporal changes in cardiac angiogenesis in a mouse IH model. Adult male C57BI/6 J mice were implanted with Matrigel plugs and subjected to IH for 1-5 weeks with subsequent weekly histological evaluation of vascularization. Expression of VEGF and KKS components was also evaluated. After 3 weeks, in vivo myocardial angiogenesis and capillary density were decreased, accompanied by a late increase of VEGF and its type 2 receptor. Furthermore, IH increased left ventricular myocardium expression of the B2 bradykinin receptor, while reducing mRNA levels of B1 receptor. These results suggest that in IH, an unexpected response of the VEGF and KKS systems could explain the reduced capillary density and impaired angiogenesis in the hypoxic heart, with potential implications in hypertrophic heart malfunction.

Identifiants

pubmed: 33991464
doi: 10.14814/phy2.14863
pmc: PMC8123545
doi:

Substances chimiques

Kinins 0
Receptors, Bradykinin 0
Vascular Endothelial Growth Factor A 0
Receptors, Vascular Endothelial Growth Factor EC 2.7.10.1
Kallikreins EC 3.4.21.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e14863

Informations de copyright

© 2021 The Authors. Physiological Reports published by Wiley Periodicals LLC on behalf of The Physiological Society and the American Physiological Society.

Références

FASEB J. 2001 Jun;15(8):1487-9
pubmed: 11387266
Am J Physiol Regul Integr Comp Physiol. 2014 Nov 15;307(10):R1181-97
pubmed: 25231353
Circ Res. 2018 Jun 8;122(12):1741-1764
pubmed: 29880501
Int Immunopharmacol. 2002 Dec;2(13-14):1823-32
pubmed: 12489796
Am J Physiol. 1999 Mar;276(3):E443-9
pubmed: 10070008
Am J Hypertens. 2016 Mar;29(3):372-8
pubmed: 26208670
Mol Vis. 2009;15:296-311
pubmed: 19204789
Am J Physiol Heart Circ Physiol. 2002 Dec;283(6):H2371-8
pubmed: 12388304
J Appl Physiol (1985). 2012 Sep 1;113(5):791-8
pubmed: 22773770
Am J Physiol Heart Circ Physiol. 2002 Jul;283(1):H156-64
pubmed: 12063286
Am J Respir Crit Care Med. 2008 Jan 15;177(2):227-35
pubmed: 17962641
J Appl Physiol (1985). 2005 Sep;99(3):807-13
pubmed: 15890760
Transl Res. 2011 Jul;158(1):1-13
pubmed: 21708351
Int J Mol Sci. 2019 Nov 08;20(22):
pubmed: 31717266
Nat Rev Mol Cell Biol. 2006 May;7(5):359-71
pubmed: 16633338
Braz J Med Biol Res. 2005 Jun;38(6):861-8
pubmed: 15933779
J Biol Chem. 2001 May 11;276(19):16587-91
pubmed: 11340086
Hypertension. 2003 May;41(5):1118-23
pubmed: 12654712
ILAR J. 2009;50(3):262-81
pubmed: 19506313
Nat Protoc. 2006;1(4):1971-6
pubmed: 17487185
PLoS One. 2018 May 18;13(5):e0197486
pubmed: 29775479
JAMA. 2000 Apr 12;283(14):1829-36
pubmed: 10770144
Ups J Med Sci. 2013 May;118(2):65-74
pubmed: 23441597
Am J Respir Crit Care Med. 2013 Jan 1;187(1):90-8
pubmed: 23155141
Angiology. 2010 Feb;61(2):145-56
pubmed: 19939823
Inflamm Res. 2019 Oct;68(10):845-855
pubmed: 31218444
Am J Physiol Heart Circ Physiol. 2009 Aug;297(2):H829-35
pubmed: 19561313
Physiology (Bethesda). 2014 Jan;29(1):39-48
pubmed: 24382870
PLoS One. 2008;3(12):e4042
pubmed: 19112498
Neuropeptides. 2010 Apr;44(2):145-54
pubmed: 20045558
J Biol Chem. 2013 Nov 15;288(46):33226-40
pubmed: 24108126
J Biol Chem. 2002 Oct 18;277(42):39728-38
pubmed: 12145288
Chest. 1995 Jun;107(6):1538-44
pubmed: 7781343
Cardiovasc Res. 2010 Oct 1;88(1):159-67
pubmed: 20495186
Antioxid Redox Signal. 2007 Jun;9(6):723-9
pubmed: 17511587
J Appl Physiol (1985). 2005 Sep;99(3):1064-9
pubmed: 15879170
Cardiovasc Res. 2008 Oct 1;80(1):106-13
pubmed: 18566101
Physiology (Bethesda). 2009 Apr;24:97-106
pubmed: 19364912
Pharmacol Ther. 2012 Jul;135(1):94-111
pubmed: 22537664
J Hum Hypertens. 2009 Dec;23(12):773-82
pubmed: 19675586
J Bras Pneumol. 2016 May-Jun;42(3):211-4
pubmed: 27383935
Circulation. 2001 Jan 2;103(1):125-32
pubmed: 11136697
J Biol Chem. 2004 May 21;279(21):22102-7
pubmed: 15033977
Front Pediatr. 2015 Jun 22;3:58
pubmed: 26157787
J Appl Physiol (1985). 2005 Nov;99(5):2028-35
pubmed: 16002771
Curr Pharm Des. 2006;12(26):3423-35
pubmed: 17017936
J Appl Physiol (1985). 2007 Feb;102(2):557-63
pubmed: 17082365
Br J Pharmacol. 1998 Jul;124(6):1286-92
pubmed: 9720802
J Biol Chem. 2002 Jan 18;277(3):2028-32
pubmed: 11711543
Arterioscler Thromb Vasc Biol. 2009 May;29(5):617-9
pubmed: 19369653
Braz J Med Biol Res. 2000 Jun;33(6):701-8
pubmed: 10829098
Circulation. 2009 Sep 22;120(12):1065-74, 9 p following 1074
pubmed: 19738140
Front Cardiovasc Med. 2019 Mar 06;6:20
pubmed: 30895179
Methods Enzymol. 1995;248:663-75
pubmed: 7674953
Cardiovasc Res. 2004 Feb 15;61(3):559-69
pubmed: 14962486
Nat Med. 1999 May;5(5):495-502
pubmed: 10229225
Obesity (Silver Spring). 2011 Nov;19(11):2167-74
pubmed: 21799478
Br J Pharmacol. 1993 Feb;108(2):318-22
pubmed: 8383560
Am J Respir Crit Care Med. 1997 Oct;156(4 Pt 1):1114-9
pubmed: 9351610
Chest. 2015 Jan;147(1):266-274
pubmed: 25560865
Microvasc Res. 2010 Sep;80(2):188-94
pubmed: 20362592
J Clin Invest. 1995 Oct;96(4):1897-904
pubmed: 7560081
Proc Natl Acad Sci U S A. 2020 Jan 7;117(1):779-786
pubmed: 31848250
J Cell Biol. 1998 Jun 29;141(7):1659-73
pubmed: 9647657
Circulation. 2003 Jun 24;107(24):3093-100
pubmed: 12821589
BMC Mol Biol. 2009 Feb 08;10:7
pubmed: 19200403
Curr Pharm Des. 2011;17(25):2654-62
pubmed: 21728987

Auteurs

Bruna Visniauskas (B)

Departamento de Psicobiologia, Universidade Federal de São Paulo, São Paulo, Brazil.

Juliana C Perry (JC)

Departamento de Psicobiologia, Universidade Federal de São Paulo, São Paulo, Brazil.

Guiomar N Gomes (GN)

Departmento de Fisiologia, Universidade Federal de São Paulo, São Paulo, Brazil.

Amanda Nogueira-Pedro (A)

Departamento de Biofísica, Universidade Federal de São Paulo, São Paulo, Brazil.

Edgar J Paredes-Gamero (EJ)

Departamento de Biofísica, Universidade Federal de São Paulo, São Paulo, Brazil.

Sergio Tufik (S)

Departamento de Psicobiologia, Universidade Federal de São Paulo, São Paulo, Brazil.

Jair R Chagas (JR)

Departamento de Psicobiologia, Universidade Federal de São Paulo, São Paulo, Brazil.
Departamento de Biofísica, Universidade Federal de São Paulo, São Paulo, Brazil.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH